• 4217 Citations
  • 34 h-Index
1978 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Jennifer D Black is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 1 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects

LABORATORY CANCER RESEARCH CENTER

Cerny, R., Issenberg, P., Bresnick, E., Kuszynski, C. A., Christman, J., Lynch, J. C., Tempero, M., Nagel, D., Smith, D. L., Kuszynski, C. A., Pour, P., Vose, J. M., Hollingsworth, T., Rogan, E. G., Bridge, J. A., Sherman, S., Lawson, T. A., Johnson, D. R., Kessinger, M. A., Cowan, K. H., Hollingsworth, T., Rogan, E. G., Bridge, J. A., Volsky, D., Conrad, R., Nagel, D., Rhode, S., Ruddon, R., Ramspott, E., Pour, P., Gmeiner, W., Lewis, R. E., Borgstahl, G. E., Caplan, S. H., Band, H., Ganti, A. K. P., Meza, J. L., Black, J. D., Guda, B., Wang, J., Semerad, C. L. & Wang, G.

National Institutes of Health

7/1/847/31/21

Project: Research project

  • Research Output

    • 4217 Citations
    • 34 h-Index
    • 71 Article
    • 6 Review article
    • 3 Comment/debate

    Erratum: Characterization of CDK(5) inhibitor, 20-223 (aka CP668863) for colorectal cancer therapy (Oncotarget (2018) 9 (5216-5232) DOI: 10.18632/oncotarget.23749)

    Robb, C. M., Kour, S., Contreras, J. I., Agarwal, E., Barger, C. J., Rana, S., Sonawane, Y., Neilsen, B. K., Taylor, M., Kizhake, S., Thakare, R. N., Chowdhury, S., Wang, J., Black, J. D., Hollingsworth, M. A., Brattain, M. G. & Natarajan, A., Jun 23 2020, In : Oncotarget. 11, 25, p. 2462-2463 2 p.

    Research output: Contribution to journalComment/debate

    Open Access
  • Prognostic and therapeutic implications of NHERF1 expression and regulation in colorectal cancer

    Leiphrakpam, P. D., Lazenby, A. J., Chowdhury, S., Smith, L. M., Mathiesen, M., Brattain, M. G., Wang, J., Black, J. D. & Are, C., Mar 1 2020, In : Journal of Surgical Oncology. 121, 3, p. 547-560 14 p.

    Research output: Contribution to journalArticle

  • Selective inhibition of histone deacetylases 1/2/6 in combination with gemcitabine: A promising combination for pancreatic cancer therapy

    Laschanzky, R. S., Humphrey, L. E., Ma, J., Smith, L. M., Enke, T. J., Shukla, S. K., Dasgupta, A., Singh, P. K., Howell, G. M., Brattain, M. G., Ly, Q. P., Black, A. R. & Black, J. D., Sep 2019, In : Cancers. 11, 9, 1327.

    Research output: Contribution to journalArticle

    Open Access
  • 3 Scopus citations

    Characterization of CDK(5) inhibitor, 20-223 (aka CP668863) for colorectal cancer therapy

    Robb, C. M., Kour, S., Contreras, J. I., Agarwal, E., Barger, C. J., Rana, S., Sonawane, Y., Neilsen, B. K., Taylor, M., Kizhake, S., Thakare, R. N., Chowdhury, S., Wang, J., Black, J. D., Hollingsworth, M. A., Brattain, M. G. & Natarajan, A., 2018, In : Oncotarget. 9, 4, p. 5216-5232 17 p.

    Research output: Contribution to journalArticle

  • 8 Scopus citations

    Crosstalk between PKCα and PI3K/AKT Signaling Is Tumor Suppressive in the Endometrium

    Hsu, A. H., Lum, M. A., Shim, K. S., Frederick, P. J., Morrison, C. D., Chen, B., Lele, S. M., Sheinin, Y. M., Daikoku, T., Dey, S. K., Leone, G., Black, A. R. & Black, J. D., Jul 17 2018, In : Cell Reports. 24, 3, p. 655-669 15 p.

    Research output: Contribution to journalArticle

  • 7 Scopus citations